In the Botulism Outbreak, the One Name the FDA Decided You Shouldn’t See

In the Botulism Outbreak, the One Name the FDA Decided You Shouldn’t See

Marler Blog
Marler BlogJun 2, 2026

Key Takeaways

  • FDA redacted supplier name despite public record of Dairy Farmers of America
  • 48 infants hospitalized in 17 states from contaminated ByHeart formula
  • Redaction cited exemption (b)(5), typically for internal deliberations
  • Organic West supplied milk powder; DFA dried it in Nevada
  • Transparency lapses impede industry safety improvements and public trust

Pulse Analysis

The ByHeart infant‑formula botulism crisis highlights a stark tension between public health transparency and agency discretion. While the FDA’s incident summary traced the contaminated ingredient to a specific dairy processor, it blacked out the supplier’s identity, invoking the deliberative‑process privilege. This exemption is intended to shield internal discussions, not factual findings, and its misuse raises legal questions about the agency’s obligation to disclose material information that directly impacts consumer safety.

Industry observers note that the redacted entities—Dairy Farmers of America’s Fallon, Nevada plant and its subcontractor Organic West—were already named in the FDA’s own outbreak advisory and in trade publications. By concealing these details, the agency not only contradicts its own disclosures but also deprives other formula manufacturers of critical supply‑chain insights. Knowledge of the implicated milk‑powder source could prompt tighter sourcing standards, more rigorous testing protocols, and proactive risk assessments across the sector, reducing the likelihood of a repeat incident.

For families and legal advocates, the omission undermines accountability. The 48 affected infants and their caregivers deserve a complete factual record to understand how the toxin entered the product and to pursue appropriate remedies. Restoring the redacted information would align the FDA’s practices with the public‑health purpose of outbreak reports, reinforce trust in regulatory oversight, and ensure that the lessons from this tragedy are fully integrated into future food‑safety policies.

In the Botulism Outbreak, the One Name the FDA Decided You Shouldn’t See

Comments

Want to join the conversation?